Kogan Elona Esq.
Known title: General Counsel and SecretaryCIK: 0001679971
Associated companies
Transaction History
| SEER | ▼ Sell | Open Market | 12,684 | $20K | 2/22/2024 | View on chart |
| SEER | ▲ Buy | Grant | 123,153 | $0 | 2/6/2024 | View on chart |
| SEER | ▼ Sell | Open Market | 8,182 | $14K | 12/4/2023 | View on chart |
| SEER | ▼ Sell | Open Market | 5,951 | $25K | 2/21/2023 | View on chart |
| SEER | ▲ Buy | Grant | 70,000 | $0 | 2/15/2023 | View on chart |
| SEER | ▼ Sell | Open Market | 8,185 | $73K | 6/8/2022 | View on chart |
| SEER | ▲ Buy | Grant | 62,000 | $0 | 2/8/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 28, 2026
Seer to Present Proteomics Data at HUPO 2026; CFO Transition Announced
Seer Inc. will share early results from its PRECISE-SG100K proteomics study with Nanyang Technological University at the HUPO 2026 conference. The company also announced a transition in its Chief Financial Officer role. These developments provide updates on the firm's scientific progress and leadership structure.
Seer to Present Proteomics Data at HUPO 2026; CFO Transition Announced. Seer Inc. will share early results from its PRECISE-SG100K proteomics study with Nanyang Technological University at the HUPO 2026 conference. The company also announced a transition in its Chief Financial Officer role. These developments provide updates on the firm's scientific progress and leadership structure.